Psychiatry · Red Bank, NJ
NPI
1467449769
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
225 Highway 35
Red Bank, NJ, 07701
Phone (732) 741-3263
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
6,812 prescriptions
Company payments, 2025
$113K
From 15 companies
Medicare prescription drug claims, 2024
In 2024, the drug Robert C Bransfield prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 498 prescriptions and refills. In total Robert C Bransfield wrote 6,812 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Bupropion Xl Bupropion Hcl | 498 | 501 | 46 | $5,888 |
| Lamotrigine Generic | 415 | 416 | 45 | $2,281 |
| Trazodone Hcl Generic | 413 | 435 | 62 | $2,775 |
| Alprazolam Generic | 326 | 326 | 59 | $1,939 |
| Escitalopram Oxalate Generic | 307 | 312 | 43 | $1,892 |
| Sertraline Hcl Generic | 283 | 299 | 40 | $1,450 |
| Paroxetine Hcl Generic | 199 | 210 | 28 | $5,546 |
| Duloxetine Hcl Generic | 197 | 201 | 18 | $1,245 |
| Topiramate Generic | 192 | 201 | 36 | $1,164 |
| Memantine Hcl Generic | 182 | 191 | 31 | $2,268 |
| Quetiapine Fumarate Generic | 164 | 164 | 24 | $923 |
| Mirtazapine Generic | 163 | 163 | 23 | $1,640 |
| Doxepin Hcl Generic | 151 | 153 | 26 | $2,992 |
| Prazosin Hcl Generic | 141 | 149 | 20 | $3,214 |
| Pregabalin Generic | 125 | 125 | 14 | $1,075 |
Brand drugs: 648 claims; generic drugs: 6,164 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert C Bransfield $113K ($113K in general payments such as food, travel and fees) from 15 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $111K.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 115 | $111K |
| Jazz Pharmaceuticals Inc. JAZZ | 13 | $346 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $273 |
| Bausch Health US, LLC BHC | 17 | $226 |
| Alkermes, Inc. ALKS | 11 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $173 |
| Axsome Therapeutics, Inc. AXSM | 5 | $170 |
| Abbvie Inc. ABBV | 11 | $145 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $96.21 |
| Almatica Pharma LLC | 5 | $78.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.